Clinical Trials Patient Summaries
Prostate cancer clinical trials descriptions written in formats that are easily understood by patients. Includes information identifying the locations and contacts for each trial.
EvoPAR Pro2 Patient Summary – High-Risk Prostate Cancer
Saruparib is a new pill that blocks PARP1, a protein cancer cells use to repair DNA. Laboratory and early‑phase studies indicated 60 mg once a...
IDeate/Prostate02 Patient Summary – Metastatic Castration Resistant
MK-2400-01A: Substudy of I-DXd-based Treatment Combinations or as Monotherapy in mCRPC Testing I-DXd alone or in combination with other treatments...
I-DXd Patient Summary – Metastatic Castration Resistant
Phase 3 Study of I-DXd Versus Docetaxel in mCRPC (MK-2400-001/IDeate-Prostate01) Testing I-DXd alone versus docetaxel for people with metastatic...
ProstACT Global Patient Summary – Metastatic Castration Resistant
ProstACT Global: A Phase 3 study of 177Lu rosopatamab tetraxetan (TLX591) plus standard of care (SoC) versus SoC alone in patients with metastatic...
XALute Patient Summary – Metastatic Castration Resistant
A research study for men with advanced prostate cancer. A Phase 3, open-label, multicenter, randomized study of Xaluritamig vs Cabazitaxel or second...
MEVPRO-1 Patient Summary – Metastatic Castration Resistant
Background Information: Prostate cancer, one of the most common types of cancer, becomes metastatic when it spreads to other parts of the body....
MEVPRO-2 Patient Summary – Metastatic Castration Resistant
Background Information: Prostate cancer, one of the most common types of cancer, becomes metastatic when it spreads to other parts of the...
MEVPRO-3 Patient Summary – Metastatic Castration Sensitive
Background Information: Prostate cancer is one of the most common types of cancer. It becomes “metastatic” when it spreads to other parts of the...
Omaha-003 Patient Summary – Metastatic Castration Resistant
This clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and failed to respond to drugs or surgery...
Omaha-004 Patient Summary – Metastatic Castration Resistant
This clinical trial is for participants who have metastatic castration-resistant prostate cancer (mCRPC) and whose cancer progressed on or after...
MK-5684-01A Patient Summary – Metastatic Castration Resistant
Background Information Metastatic castration-resistant prostate cancer (mCRPC) is a form of prostate cancer that keeps growing even when male...
Find Your Trial
All Diagnoses
Low Risk
Intermediate Risk
High Risk
Cancer Recurrence
Non-Metastatic Castration Resistant
Metastatic Castration Sensitive
Metastatic Castration Resistant
Neuroendocrine
This information is for educational purposes only and not intended as medical advice.
Patients should consult their medical doctor for advice and recommendations about specific clinical trials.